105 Results for "

EZH2 inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (105)

105 Results for "EZH2 inhibitor" in MCE Product Catalog:

105
105 Publications Verification
Cat. No.: HY-13470
CAS No.: 1346574-57-9
Purity:  99.76%
Synonyms: GSK2816126A
Research Areas:  

Cancer

GSK126 (GSK2816126A) is a potent, highly selective inhibitor of EZH2 methyltransferase with an IC50 of 9.9 nM .
loading...
    loading...
100
100 Cited Publications
Cat. No.: HY-13803
CAS No.: 1403254-99-8
Purity:  99.93%
Synonyms: EPZ-6438; E-7438
Research Areas:  

Cancer

Tazemetostat (EPZ-6438) is a potent, selective and orally available EZH2 inhibitor. Tazemetostat inhibits the activity of human polycomb repressive complex 2 (PRC2)-containing wild-type EZH2 with a Ki value of 2.5 nM. Tazemetostat inhibits EZH2 with IC50s of 11 and 16 nM in peptide assay and nucleosome assay, respectively. Tazemetostat inhibits rat EZH2 with an IC50 of 4 nM. Tazemetostat also inhibits EZH1 with an IC50 of 392 nM. Tazemetostat induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells .
loading...
    loading...
37
37 Cited Publications
Cat. No.: HY-10442
CAS No.: 102052-95-9
Purity:  99.80%
Synonyms: DZNep; 3-Deazaneplanocin
3-Deazaneplanocin A (DZNep) is a potent histone methyltransferase EZH2 inhibitor . 3-Deazaneplanocin A is a potent S-adenosylhomocysteine hydrolase (AHCY) inhibitor. 3-Deazaneplanocin A shows anti-orthopoxvirus activity .
loading...
    loading...
37
37 Cited Publications
Cat. No.: HY-12186
CAS No.: 120964-45-6
Purity:  99.89%
Synonyms: DZNep hydrochloride; NSC 617989 hydrochloride; 3-Deazaneplanocin hydrochloride
3-Deazaneplanocin A hydrochloride (DZNep hydrochloride) is a potent histone methyltransferase EZH2 inhibitor . 3-Deazaneplanocin A hydrochlorideis a potent S-adenosylhomocysteine hydrolase (AHCY) inhibitor . 3-Deazaneplanocin A hydrochloride also has anti-orthopoxvirus and anti-variola activities .
loading...
    loading...
33
33 Cited Publications
Cat. No.: HY-13500
CAS No.: 1346704-33-3
Purity:  99.88%
Research Areas:  

Cancer

GSK343, a chemical probe, is a highly potent and selective EZH2 inhibitor with an IC50 of 4 nM.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-15646
CAS No.: 1431612-23-5
Purity:  99.87%
Research Areas:  

Cancer

UNC1999, a chemical probe, is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC50s of <10 nM and 45 nM, repectively.
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-12856
CAS No.: 1346572-63-1
Purity:  99.80%
Research Areas:  

Cancer

GSK503 is a potent and specific inhibitor of EZH2 methyltransferase with Ki app values of 3 to 27 nM.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-15555
CAS No.: 1396772-26-1
Purity:  99.46%
Research Areas:  

Cancer

EPZ005687 is a potent and selective inhibitor of EZH2 with Ki of 24 nM, and has 50-fold selectivity against EZH1 and 500-fold selectivity against 15 other protein methyltransferases.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-133129
CAS No.: 2225938-17-8
Purity:  98.92%
MS1943 is an orally active selective HyT degrader of EZH2 that effectively reduces EZH2 levels in cells. MS1943 has anticancer activity and exhibits cytotoxic effects in a variety of TNBC cells while sparing normal cells. In addition, MS1943 maintains high potency (IC50=120 nM) in inhibiting EZH2 methyltransferase activity and is highly selective for EZH2. (Structure Note: RED, EZH2 ligand (HY-148458); Blue, Hyt (HY-W001578)) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-101512
CAS No.: 2089148-72-9
Purity:  98.78%
Research Areas:  

Cancer

A-395, a chemical probe, is an antagonist of polycomb repressive complex 2 (PRC2) protein-protein interactions that potently inhibits the trimeric PRC2 complex (EZH2-EED-SUZ12) with an IC50 of 18 nM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-148333
CAS No.: 2225938-86-1
Purity:  98.00%
Research Areas:  

Cancer

MS177 is an effective and fast-acting EZH2 degrader. MS177 is a PROTAC that consists of a CRBN ligand, linker, and a potent enzymatic EZH2 inhibitor C24 (C24 IC50): 12 nM). MS177 effectively depletes both canonical EZH2-PRC2 and noncanonical EZH2-cMyc complexes. MS177 induces leukaemia cell growth inhibition, apoptosis and cell cycle progression arrest .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16986
CAS No.: 1598383-40-4
Research Areas:  

Cancer

EPZ011989 is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor with metabolic stability. EPZ011989 has inhibitory inhibition for EZH2 with a Ki value of <3 nM. EPZ011989 shows robust methyl mark inhibition and anti-tumor activity. EPZ011989 can be used for the research of various cancers . EPZ011989 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100846
CAS No.: 1913252-04-6
Purity:  98.14%
Research Areas:  

Cancer

JQEZ5 is a potent and selective EZH2 lysine methyltransferase inhibitor. JQEZ5 SAM-competitively inhibits polycomb repressive complex 2 (PRC2) with an IC50 of 80 nM. JQEZ5 has anti-tumor effects .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16986B
CAS No.: 2095432-26-9
Research Areas:  

Cancer

EPZ011989 hydrochloride is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor, with a Ki value of <3 nM. EPZ011989 shows anti-tumor activity. EPZ011989 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16986A
CAS No.: 1598383-41-5
Research Areas:  

Cancer

EPZ-011989 trifluoroacetate is a potent and orally active Zeste Homolog 2 (EZH2) inhibitor with metabolic stability. EPZ-011989 trifluoroacetate has inhibitory inhibition for EZH2 with a Ki value of <3 nM. EPZ-011989 trifluoroacetate shows robust methyl mark inhibition and anti-tumor activity. EPZ-011989 trifluoroacetate can be used for the research of various cancers . EPZ011989 (trifluoroacetate) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N5024
CAS No.: 173932-75-7
Gambogenic acid is an active ingredient that can be isolated from gamboge. Gambogenic acid acts as an effective inhibitor of EZH2, specifically and covalently binds to Cys668 within the EZH2-SET domain, and induces EZH2 ubiquitination. Gambogenic acid can be used for the research of cancer .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-15573
CAS No.: 1418308-27-6
Purity:  99.78%
Synonyms: KB-145943
Research Areas:  

Cancer

EI1 (KB-145943) is a potent and selective EZH2 inhibitor with IC50 of 15 nM and 13 nM for EZH2 (WT) and EZH2 (Y641F), respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-153191
CAS No.: 2098545-98-1
Purity:  99.68%
Research Areas:  

Cancer

EZH2-IN-15 is a EZH2 inhibitor. EZH2-IN-15 has anti-tumor activity, and can be used for research of H3K27me3-dependent tumors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148458
CAS No.: 1979157-17-9
Purity:  99.02%
Research Areas:  

Cancer

EZH2-IN-14 is a selective EZH2 (Histone Methyltransferase) inhibitor with an IC50 of 12 nM. EZH2-IN-14 inhibits the methyltransferase activity of EZH2/PRC2 (that is, reducing H3K27me3). EZH2-IN-14 shows >200-fold selective for EZH2 over the highly homologous H3K27 methyltransferase EZH1 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-103682
CAS No.: 1616287-82-1
Purity:  99.71%
Research Areas:  

Cancer

PF-06726304 is a potent and selective EZH2 inhibitor. PF-06726304 inhibits wild-type and Y641N mutant EZH2 with Kis of 0.7 and 3.0 nM, respectively. PF-06726304 displays robust antitumor growth activity .
loading...
    loading...